Is there a biological basis for geriatric pharmacotherapy?
The problem of developing a geriatric pharmacotherapy is briefly discussed. It is stressed that combined scientific knowledge from biological, clinical and pharmacological research should be used as basis. However, in applied (clinical and pharmacological) gerontology, direct relations to basic experimental gerontology are often avoided, because of its seemingly theoretical character. With some examples, it is pointed out that during the recent past, biological-aging research has gained new knowledge, particularly on skeletal muscle and CNS aging, that can be used in the concept of a specific geriatric pharmacotherapy.